Levitra: Restore Confidence with Effective Erectile Function
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $2.36 | $68.80 $47.30 (31%) | 🛒 Add to cart |
| 30 | $2.01 | $103.20 $60.20 (42%) | 🛒 Add to cart |
| 60 | $1.43 | $206.40 $86.00 (58%) | 🛒 Add to cart |
| 90 | $1.24 | $309.60 $111.80 (64%) | 🛒 Add to cart |
| 120 | $1.15 | $412.80 $137.60 (67%) | 🛒 Add to cart |
| 180 | $1.05 | $619.20 $189.20 (69%) | 🛒 Add to cart |
| 270 | $0.96 | $928.80 $258.00 (72%) | 🛒 Add to cart |
| 360 | $0.86
Best per pill | $1238.40 $309.60 (75%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.87 | $38.70 (0%) | 🛒 Add to cart |
| 20 | $2.79 | $77.40 $55.90 (28%) | 🛒 Add to cart |
| 30 | $2.44 | $116.10 $73.10 (37%) | 🛒 Add to cart |
| 60 | $2.01 | $232.20 $120.40 (48%) | 🛒 Add to cart |
| 90 | $1.91 | $348.30 $172.00 (51%) | 🛒 Add to cart |
| 120 | $1.72 | $464.40 $206.40 (56%) | 🛒 Add to cart |
| 180 | $1.58 | $696.60 $283.80 (59%) | 🛒 Add to cart |
| 270 | $1.40 | $1044.90 $378.40 (64%) | 🛒 Add to cart |
| 360 | $1.19
Best per pill | $1393.20 $430.00 (69%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Levitra (vardenafil HCl) is a prescription medication specifically formulated to treat erectile dysfunction (ED) in adult men. As a potent and selective phosphodiesterase type 5 (PDE5) inhibitor, it works by increasing blood flow to the penis, facilitating the achievement and maintenance of an erection sufficient for satisfactory sexual activity. Clinical studies demonstrate its efficacy across a broad range of patients, including those with underlying conditions such as diabetes and hypertension. It is not an aphrodisiac and requires sexual stimulation to be effective.
Features
- Active Pharmaceutical Ingredient: Vardenafil hydrochloride.
- Available Strengths: 2.5 mg, 5 mg, 10 mg, and 20 mg film-coated tablets.
- Mechanism of Action: Selective inhibition of phosphodiesterase type 5 (PDE5).
- Pharmacokinetic Profile: Rapid onset of action, with a median time to maximum plasma concentration (Tmax) of approximately 0.5 to 2.5 hours.
- Administration: Oral tablet, taken with or without food (though high-fat meals may delay absorption).
- Excipients: Microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, yellow ferric oxide, and red ferric oxide.
Benefits
- Rapid and Reliable Efficacy: Achieve erections suitable for sexual intercourse, often within 25-60 minutes of dosing.
- Improved Success Rates: Significant improvement in the ability to achieve and maintain an erection, as measured by the International Index of Erectile Function (IIEF) questionnaire.
- Enhanced Sexual Confidence: Success in the bedroom can lead to reduced anxiety and improved self-esteem and overall relationship satisfaction.
- Flexible Dosing Options: A range of tablet strengths allows for individualized treatment plans tailored to patient response and tolerability.
- Consistent Performance: Demonstrated efficacy even in challenging patient subgroups, such as men with diabetes-related ED.
Common use
Levitra is indicated for the treatment of erectile dysfunction, the recurrent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. It is used on an as-needed basis by adult males. Its use is predicated on the presence of sexual stimulation; it will not cause an erection spontaneously. Diagnosis of ED should be based on a thorough medical and psychosocial evaluation to identify potential underlying causes and establish appropriate treatment.
Dosage and direction
The recommended starting dose for most patients is 10 mg, taken orally approximately 60 minutes before anticipated sexual activity. The dose may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and tolerability. The dosing frequency should not exceed once per 24-hour period.
- For patients 65 years and older, and those with hepatic impairment (Child-Pugh B), the recommended starting dose is 5 mg.
- The maximum recommended dose for patients with severe hepatic impairment (Child-Pugh C) is 5 mg, and use is not recommended in patients on dialysis or with severe renal impairment (CrCl <30 mL/min).
- The 2.5 mg dose is indicated for daily use, offering a low-dose, continuous option for men who anticipate frequent sexual activity (at least twice weekly). This daily dosing regimen should be taken at approximately the same time each day, without regard to timing of sexual activity.
The tablet should be swallowed whole with a glass of water. It can be taken with or without food, though consumption with a high-fat meal may delay the time to onset of effect.
Precautions
- Cardiovascular Status: Sexual activity poses a potential cardiac risk. Therefore, Levitra, like other treatments for ED, is not recommended for men for whom sexual activity is inadvisable due to underlying cardiovascular status. A thorough cardiovascular assessment is recommended prior to initiating any treatment for ED.
- Prolonged Erection: Patients who experience an erection lasting longer than 4 hours (priapism) should seek immediate medical attention. Permanent damage to the penile tissues can occur if priapism is not treated promptly.
- Sudden Vision Loss: Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported rarely post-marketing in association with PDE5 inhibitor use. Patients who experience a sudden loss of vision in one or both eyes should stop taking Levitra and seek immediate medical attention.
- Sudden Hearing Loss: Cases of sudden decrease or loss of hearing, sometimes accompanied by tinnitus and dizziness, have been reported. Patients experiencing these symptoms should discontinue Levitra and seek prompt medical attention.
- Alpha-Blockers and Blood Pressure: Concomitant use with alpha-blockers (medications for hypertension or prostate problems) can lead to a symptomatic lowering of blood pressure (dizziness, lightheadedness, fainting). Co-administration is generally not recommended.
- Other Conditions: Use with caution in patients with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, or Peyronie’s disease), and in patients who have conditions that may predispose them to priapism (e.g., sickle cell anemia, multiple myeloma, or leukemia).
Contraindications
Levitra is contraindicated in the following patient populations:
- Patients taking any form of organic nitrates (e.g., nitroglycerin, isosorbide mononitrate or dinitrate) or nitric oxide donors, either regularly or intermittently. Concomitant use can cause a severe and potentially life-threatening drop in blood pressure.
- Patients taking guanylate cyclase stimulators, such as riociguat.
- Patients with a known hypersensitivity to vardenafil or any of the excipients in the formulation.
- Patients with severe hepatic impairment (Child-Pugh C) for whom a recommended dose cannot be determined.
- Patients with end-stage renal disease requiring dialysis.
Possible side effect
Like all medicines, Levitra can cause side effects, although not everybody gets them. The most common side effects are related to its vasodilatory effects and are generally mild to moderate and transient.
- Very Common (≥1/10): Headache.
- Common (≥1/100 to <1/10): Flushing, dizziness, dyspepsia (indigestion), nasal congestion, rhinitis, myalgia (muscle ache), back pain.
- Uncommon (≥1/1,000 to <1/100): Palpitations, tachycardia (increased heart rate), nausea, elevated liver enzymes, blurred vision, changes in color vision, photophobia (light sensitivity), conjunctivitis, erectile duration increased, fatigue.
- Rare (≥1/10,000 to <1/1,000): Hypotension (low blood pressure), syncope (fainting), priapism, NAION, sudden hearing loss, hypersensitivity reactions (including rash, hives, and swelling of the face).
- Frequency not known: Seizure, transient global amnesia.
Drug interaction
Levitra is primarily metabolized by the cytochrome P450 enzyme CYP3A4, with contributions from CYP3A5 and CYP2C isoforms. Consequently, its pharmacokinetics can be significantly affected by other drugs.
- Nitrates: Absolute Contraindication. Concomitant use can cause profound hypotension, syncope, stroke, or myocardial infarction.
- Alpha-Adrenergic Blocking Agents (e.g., doxazosin, tamsulosin): Co-administration can lead to symptomatic hypotension. Use is not recommended.
- Potent CYP3A4 Inhibitors:
- Ketoconazole, Itraconazole, Ritonavir: The maximum recommended dose of Levitra is 5 mg in a 24-hour period when co-administered.
- Indinavir, Atazanavir, Clarithromycin: A dose reduction of Levitra should be considered.
- Moderate CYP3A4 Inhibitors (e.g., erythromycin, aprepitant, fluconazole): A dose reduction of Levitra should be considered. The maximum recommended dose is 5 mg.
- CYP3A4 Inducers (e.g., rifampin, phenobarbital, phenytoin, carbamazepine, St. John’s Wort): May decrease vardenafil plasma concentrations, potentially reducing efficacy. Consideration of a dose adjustment may be necessary.
- Antihypertensives: Levitra may add to the blood-pressure-lowering effects of other antihypertensive agents.
- Other PDE5 Inhibitors: Concomitant use with other PDE5 inhibitors (e.g., sildenafil, tadalafil) is not recommended.
Missed dose
Levitra is taken on an as-needed basis. There is no scheduled dosing regimen to adhere to, so the concept of a “missed dose” does not apply. If a dose is not taken prior to sexual activity, it should be taken when needed for the next anticipated sexual encounter, ensuring at least 24 hours have passed since any previous dose.
Overdose
In cases of overdose, the expected clinical presentation would be an extension of the drug’s known adverse effects, primarily severe vasodilation leading to significant hypotension. Standard supportive measures should be employed, including keeping the patient in the supine position with the legs elevated to help restore blood pressure and ensure vital organ perfusion. Hemodialysis is not expected to accelerate clearance, as vardenafil is highly protein-bound and not significantly eliminated in the urine.
Storage
- Store Levitra tablets at room temperature, between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F).
- Keep the medication in its original blister package or bottle to protect it from light and moisture.
- Keep all medicines out of the sight and reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- Clinical Trial Data: A meta-analysis of randomized, double-blind, placebo-controlled trials involving over 4,000 men demonstrated that vardenafil 10 mg and 20 mg significantly improved erectile function, intercourse satisfaction, and overall satisfaction scores on the IIEF compared to placebo. Success rates for vaginal penetration were 65% and 75% for the 10 mg and 20 mg doses, respectively, versus 33% for placebo.
- Patient Reported Outcomes: Many users report high satisfaction with the speed of onset and the consistency of results. The option for daily low-dose therapy is often cited as beneficial for reducing performance anxiety and allowing for more spontaneous sexual activity.
- Special Populations: Studies in men with diabetes-associated ED have shown significant improvement, with one study reporting improved erections in 72% of men taking vardenafil 20 mg versus 13% on placebo. Similarly, studies in post-prostatectomy patients have shown promising results.
- Tolerability Profile: Reviews frequently note that side effects are generally manageable and diminish with continued use or dose adjustment. The low incidence of visual disturbances (a blue tinge to vision) compared to some other agents in its class is often mentioned positively.